You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《瑞通窝轮》【瑞通认股证牛熊证】美团涉垄断被查 股价先跌後升 较多资金即市开熊 恒指牛68708 熊67601/ 美团牛51334 熊59322 购16108 沽16119
阿思达克 04-27 10:38
市场观望多只科技股周内公布的季绩,美股隔晚个别发展。道指收报33981点,跌61点(或0.2%);纳指则升0.9%,创收市新高。恒指昨尾市沽压加剧,收报28952点,跌125点(或0.43%)。今早曾再跌逾100点,一度跌破28800点,其後回稳。 恒指好仓(牛证及认购权证)昨净流入逾5100万港元(下同),恒指淡仓(熊证及认沽权证)同日净流出逾230万元,反映投资者看好大市反弹。昨日恒指牛证街货重货区为收回价28500至28599点,而熊证街货重货区为收回价29800至29899点。

国家市场监管总局表示,根据举报依法对美团(03690)实施「二选一」等涉嫌垄断行为立案调查。美团回应将积极配合监管部门调查,严格落实相关规定,目前公司业务一切正常。有券商预料美团面对的行政处罚区间介乎40亿至120亿元人民币。美团是昨日成交最活跃股份,股价最多升近半成至321元以上,惟午後走势逆转,倒跌0.5%收市,报305元。今早跌逾2%,曾低见296.4元,考验10及20天线的支持(分别约294和298元),惟其後迅速倒升,不止收复300元关口,更一度升至312元之上的水平。昨有逾7亿元北水净买入美团。轮证资金流方面,各有超过1900万元净流入其好仓和淡仓,分别为个股好淡仓项目中资金净流入的头两位。

药明生物(02269)大股东以每股107元配售1.08亿股现有股份,套现逾115亿元,是继一月和二月後今年第三次进行配股。该股昨升上两个月高位後回落,倒跌0.2%收114.8元,今早挫6%,一度回落至108元之下,正考验10天线(109元) 支持。昨有逾300万元净流出其好仓,淡仓同日则有逾30万元净流入。

汇控(00005)今公布首季度业绩,券商预测集团期内列帐基准除税前利润介乎26.49亿至36.93亿美元,按年下跌18%至上升14.4%。市场关注汇控按季净息差表现及重组步伐。股份昨窄幅上落,收报45.1元,微升0.7%结束三连跌。今早靠稳,於45元以上徘徊。昨有逾330万元净流入其好仓,淡仓同日则有逾50万元净流出。

据报美国政府拟要求烟草公司将所有在美国出售的香烟尼古丁含量降至不成瘾水平,或驱使部份烟民转投电子烟。生产电子烟雾化组件的思摩尔(06969),上日曾急涨7.4%至58.7元,创一个月高,收市维持4.1%升幅於56.9元,或已消化季绩後的沽压。股份今早先升後回,上试58元水平见阻力,其後转跌1%。昨有逾430万元净流入其好仓,淡仓同日资金流变化不大。

瑞通相关认股证之选择:

美团轻微价外、中短期购16108,行使价:345元,2021年9月到期,实际杠杆:5.4倍

美团轻微价外、中短期沽16119,行使价:269.8元,2021年8月到期,实际杠杆:5.3倍

药明轻微价外、中短期购26864,行使价:126.88元,2021年8月到期,实际杠杆:4.8倍

汇丰轻微价外、中短期购15127,行使价:48.88元,2021年8月到期,实际杠杆:10.4倍

汇丰贴价、中短期沽15035,行使价:43.88元,2021年8月到期,实际杠杆:7.4倍

思摩轻微价外、中年期购16109,行使价:60.969元,2021年11月到期,实际杠杆:2.2倍

腾讯轻微价外、中短期购11712,行使价:729.38元,2021年10月到期,实际杠杆:7.1倍

腾讯轻微价外、中短期沽20807,行使价:555.38元,2021年8月到期,实际杠杆:8.1倍

瑞通相关牛熊证之选择:

恒指牛证68708,收回价:28500点,杠杆比率:45倍

恒指熊证67601,收回价:29390点,杠杆比率:50倍

美团牛证51334,收回价:280.2元,杠杆比率:12.6倍

美团熊证59322,收回价:346.88元,杠杆比率:5.4倍

全场最贴药明牛证66183,收回价:101.88元,杠杆比率:9.5倍

药明熊证56714,收回价:118.8元,杠杆比率:7.6倍

汇丰牛证64079,收回价:43元,杠杆比率:12.6倍

汇丰熊证59349,收回价:48.88元,杠杆比率:8.7倍

思摩牛证50724,收回价:53.08元,杠杆比率:6.7倍

腾讯牛证59297,收回价:591元,杠杆比率:17倍

腾讯熊证59309,收回价:658.88元,杠杆比率:13.5倍

重要风险通知

本结构性产品并无抵押品。

结构性产品之价格一般可急升亦可急跌,有可能损失结构性产品之全部或重大部分购买价,阁下对此应有所准备。

阁下投资前应了解产品风险,如有需要应谘询专业建议。~

重要声明:

以上资讯由第三方提供,AASTOCKS.com Limited对於任何包含於、经由、连结、下载或从任何与本网站有关服务所获得之资讯、内容或广告,不声明或保证其内容之正确性或可靠性。对於您透过本网站上之广告、资讯或要约而展示、购买或取得之任何产品、资讯资料,本公司亦不负品质保证之责任。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account